Sunday, Jan 30, 2005
Sunday, Jan 30, 2005 |
| New Delhi | ||||
|
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts: Classifieds | Employment | Obituary | New Delhi
By Our Staff Reporter
NEW DELHI, JAN. 29. Hindustan Syringes and Medical Devices Limited (HMD), the largest syringe manufacturer in Asia, has become the first company in the world to get a World Health Organisation approval for its auto-disable syringe, `Kojak Selinge', under its new product assessment procedures. The Kojak Selinge also known as K1, invented by the United Kingdom-based Star Syringe's Marc Koska, is expected to play a leading role in India's newly announced commitment to eliminate unsafe injection practices. With WHO approval, HMD's 0.5ml auto-disable syringe is now authorised for global use, including the Indian market with immediate effect. Furthermore, Kojak Selinge will also be qualified for listing in WHO-UNICEF Product Information Sheets and automatically included in its relevant database. Manufactured in India by HMD, the 0.5ml auto-disable syringe has been found by the WHO adhering to its new PQS pre-qualification procedures, which will replace WHO exists PIS system, for which K1 already had approval. Now Kojak Selinge is the first and only auto-disable syringe in the world to have been approved under both the criteria. The timing of the WHO's announcement is significant as recently the Indian government officially included the use of auto-disable syringes in the country's immunisation programme, a step announced by Minister of Health and Family Welfare. The country aims to ban the use of glass and disposable syringes in its immunisation programme as part of its efforts to protect children from the risk of injection related infectious diseases. It is estimated that the new programme will require about 300 million auto-disable syringes. A national injection policy is currently being formulated to encompass all health delivery systems for curative or immunisation purposes, according to the Union Health Minister. This is in response to a recent study on the issue of unsafe injections that revealed that over 65 per cent of injections in the country are unsafe due to use of syringes of doubtful sterility or reuse of syringes and needles. The WHO estimates that 53.6 per cent of all hepatitis B cases, 59.5 per cent of hepatitis C cases, and 24.3 per cent of HIV infections each year are attributable to unsafe injections.
Printer friendly
page
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
|
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu
|
